Brian L. Burback

Suggest Changes
Learn More
A toxicology and pharmacokinetic study of orally administered (po) IPdR (5-3iodo-2-pyrimidinone-2′deoxyribose, NSC-726188) was performed in Fischer-344 rats using a once daily (qd) × 28 days dosing(More)
PURPOSE A toxicology and pharmacokinetic study of orally administered (po) IPdR (5-3iodo-2-pyrimidinone-2'deoxyribose, NSC-726188) was performed in Fischer-344 rats using a once daily (qd) x 28 days(More)